Corrigendum to “Renal Autologous Cell Therapy to Stabilize Function in Diabetes-Related Chronic Kidney Disease: Corroboration of Mechanistic Action With Cell Marker Analysis” [Kidney International Reports Volume 7, Issue 7, July 2022, Pages 1619-1629]

Kidney International Reports 2026 Open access

Read full text
Authors: Joseph Stavas, Guido Filler, Deepak Jain, John W. Ludlow, Joydeep Basu, Richard Payne, Emily Butler, María Ferris, Tim A. Bertram
DOI: 10.1016/j.ekir.2026.106406
Cited by: 0

Abstract

Following publication of this article, additional analyses were conducted to further characterize the cellular composition of the selected renal cell (SRC) product using updated bioanalytical methodologies and orthogonal validation approaches.

Fields of Study & Subjects

Mesenchymal stem cell research Chronic Kidney Disease and Diabetes Acute Kidney Injury Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
5
Pages
106406–106406
Publication date
26 February 2026
Language
EN